Christopher Raymond Score: 23
Analyst at
Raymond James,
Piper Sandler
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-22.5%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
33%
16 W / 32 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
44%
15 W / 19 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
12%
4 W / 30 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
3%
1 W / 33 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
24%
7 W / 22 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
27%
11 W / 30 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
71%
5 W / 2 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 |
Alumis Inc.
ALMS
|
BUY |
$46.00
Est. +64%
|
$28.10 | $28.44 |
Pending
|
$24.15
-14.1%
|
| Jan 08, 2026 |
Ardelyx Inc
ARDX
|
BUY |
$19.00
Est. +171%
|
$7.00 | $8.40 |
Pending
|
$5.69
-18.8%
|
| Oct 28, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$723.00
Est. +10%
|
$654.48 | $821.11 |
Target Met
|
$614.65
-6.1%
|
| Sep 02, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$673.00
Est. +16%
|
$577.90 | $821.11 |
Target Met
|
$614.65
+6.4%
|
| May 14, 2025 |
ITeos Therapeutics Inc
ITOS
|
BUY |
$12.00
Est. +73%
|
$6.92 | $11.34 |
Miss
|
$10.15
+46.7%
|
| Nov 01, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,195.00
Est. +42%
|
$843.60 | $862.00 |
Miss
|
$614.65
-27.1%
|
| Oct 30, 2024 |
Biogen Inc
BIIB
|
BUY |
$315.00
Est. +74%
|
$181.18 | $185.00 |
Miss
|
$198.64
+9.6%
|
| Sep 25, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$344.00
Est. +4%
|
$330.92 | $335.88 |
Precision Hit (±3%)
|
$350.53
+5.9%
|
| Sep 16, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$100.00
Est. +14%
|
$87.45 | $113.51 |
Target Met
|
$123.35
+41.1%
|
| Sep 16, 2024 |
ITeos Therapeutics Inc
ITOS
|
BUY |
$36.00
Est. +116%
|
$16.70 | $14.50 |
Miss
|
$10.15
-39.2%
|
| Sep 05, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$122.00
Est. +41%
|
$86.74 | $90.01 |
Miss
|
$55.65
-35.8%
|
| Aug 27, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$107.00
Est. +21%
|
$88.69 | $93.04 |
Miss
|
$55.65
-37.3%
|
| Aug 23, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,242.00
Est. +5%
|
$1,187.66 | $1,211.20 |
Precision Hit (±3%)
|
$614.65
-48.2%
|
| Aug 23, 2024 |
Abbvie Inc
ABBV
|
BUY |
$209.00
Est. +6%
|
$197.35 | $218.66 |
Target Met
|
$221.59
+12.3%
|
| Aug 15, 2024 |
Tyra Biosciences Inc
TYRA
|
BUY |
$33.00
Est. +53%
|
$21.57 | $29.60 |
Miss
|
$28.55
+32.4%
|
| Jul 26, 2024 |
Biogen Inc
BIIB
|
BUY |
$307.00
Est. +45%
|
$211.17 | $219.44 |
Miss
|
$198.64
-5.9%
|
| Jul 19, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,166.00
Est. +10%
|
$1,063.60 | $1,211.20 |
Target Met
|
$614.65
-42.2%
|
| Jul 12, 2024 |
Biogen Inc
BIIB
|
BUY |
$313.00
Est. +32%
|
$236.80 | $237.98 |
Miss
|
$198.64
-16.1%
|
| Jul 01, 2024 |
Taysha Gene Therapies Inc
TSHA
|
BUY |
$7.00
Est. +213%
|
$2.24 | $3.31 |
Miss
|
$5.97
+166.5%
|
| Jun 18, 2024 |
Abbvie Inc
ABBV
|
BUY |
$190.00
Est. +11%
|
$171.36 | $218.66 |
Target Met
|
$221.59
+29.3%
|
| Jun 03, 2024 |
Alx Oncology Holdings Inc
ALXO
|
BUY |
$21.00
Est. +131%
|
$9.10 | $8.78 |
Miss
|
$1.58
-82.6%
|
| May 31, 2024 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$135.00
Est. +249%
|
$38.65 | $60.37 |
Miss
|
$25.38
-34.3%
|
| May 24, 2024 |
Ardelyx Inc
ARDX
|
BUY |
$15.00
Est. +108%
|
$7.20 | $7.18 |
Miss
|
$5.69
-21.0%
|
| May 22, 2024 |
Biogen Inc
BIIB
|
BUY |
$335.00
Est. +49%
|
$225.21 | $237.98 |
Miss
|
$198.64
-11.8%
|
| May 20, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,000.00
Est. +2%
|
$982.29 | $1,211.20 |
Target Met
|
$614.65
-37.4%
|
| May 07, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$456.00
Est. +10%
|
$413.42 | $519.88 |
Target Met
|
$450.69
+9.0%
|
| May 03, 2024 |
Blueprint Medicines Corp
BPMC
|
SELL |
$104.00
Est. +2%
|
$106.29 | $73.08 (Low) |
Target Met
|
$129.46
-21.8%
|
| Apr 29, 2024 |
Deciphera Pharmaceuticals Inc
DCPH
|
BUY |
$25.60
Est. +1%
|
$25.25 | $25.61 |
Bullseye Hit (±1%)
|
$25.59
+1.3%
|
| Apr 29, 2024 |
Deciphera Pharmaceuticals Inc
DCPH
|
SELL |
$25.00
Est. +1%
|
$25.29 | $25.56 (Low) |
Precision Hit (±3%)
|
$25.59
-1.2%
|
| Apr 15, 2024 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$130.00
Est. +203%
|
$42.87 | $60.37 |
Miss
|
$25.38
-40.8%
|
| Apr 09, 2024 |
Taysha Gene Therapies Inc
TSHA
|
BUY |
$9.00
Est. +236%
|
$2.68 | $3.31 |
Miss
|
$5.97
+122.8%
|
| Apr 02, 2024 |
Q32 Bio Inc.
QTTB
|
BUY |
$45.00
Est. +150%
|
$18.00 | $53.73 |
Target Met
|
$12.64
-29.8%
|
| Mar 13, 2024 |
Solid Biosciences Inc
SLDB
|
BUY |
$20.00
Est. +64%
|
$12.23 | $10.37 |
Miss
|
$7.36
-39.8%
|
| Nov 09, 2023 |
Abbvie Inc
ABBV
|
BUY |
$170.00
Est. +20%
|
$142.03 | $207.32 |
Target Met
|
$221.59
+56.0%
|
| Dec 05, 2022 |
AMGEN Inc.
AMGN
|
BUY |
$297.00
Est. +4%
|
$285.73 | - | - |
$350.53
+22.7%
|
| Nov 22, 2022 |
CalciMedica Inc
CALC
|
SELL |
$2.00
Est. +99%
|
$146.90 | - | - |
$0.87
+99.4%
|
| Nov 22, 2022 |
Graybug Vision Inc
GRAY
|
SELL |
$2.00
Est. +99%
|
$146.90 | $5.02 (Low) |
Miss
|
$5.50
+96.3%
|
| Oct 26, 2022 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$128.00
Est. +39%
|
$92.10 | - | - |
$55.65
-39.6%
|
| Jul 28, 2022 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$130.00
Est. +151%
|
$51.88 | - | - |
$25.38
-51.1%
|
| May 18, 2022 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$135.00
Est. +183%
|
$47.70 | - | - |
$25.38
-46.8%
|
| May 18, 2022 |
Blueprint Medicines Corp
BPMC
|
BUY |
$65.00
Est. +17%
|
$55.50 | - | - |
$129.46
+133.3%
|
| May 18, 2022 |
Kinnate Biopharma Inc
KNTE
|
BUY |
$30.00
Est. +201%
|
$9.96 | - | - |
$2.65
-73.4%
|
| May 18, 2022 |
CalciMedica Inc
CALC
|
SELL |
$2.00
Est. +99%
|
$171.81 | - | - |
$0.87
+99.5%
|
| May 18, 2022 |
Graybug Vision Inc
GRAY
|
SELL |
$2.00
Est. +99%
|
$171.81 | $5.02 (Low) |
Miss
|
$5.50
+96.8%
|
| Apr 07, 2022 |
Biogen Inc
BIIB
|
SELL |
$200.00
Est. +5%
|
$211.64 | - | - |
$198.64
+6.1%
|
| Feb 08, 2022 |
AMGEN Inc.
AMGN
|
BUY |
$255.00
Est. +7%
|
$238.96 | - | - |
$350.53
+46.7%
|
| Feb 02, 2022 |
Abbvie Inc
ABBV
|
BUY |
$160.00
Est. +15%
|
$138.62 | - | - |
$221.59
+59.9%
|
| Sep 27, 2021 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$170.00
Est. +92%
|
$88.66 | - | - |
$25.38
-71.4%
|
Alumis Inc.
ALMS
Mar 10, 2026
Signal & Target
BUY
$46.00
Start Price
$28.10
Best Price (1Y)
$28.44
Current Price
$24.15
Return
-14.1%
Ardelyx Inc
ARDX
Jan 08, 2026
Signal & Target
BUY
$19.00
Start Price
$7.00
Best Price (1Y)
$8.40
Current Price
$5.69
Return
-18.8%
Regeneron Pharmaceuticals, Inc.
REGN
Oct 28, 2025
Signal & Target
BUY
$723.00
Start Price
$654.48
Best Price (1Y)
$821.11
Current Price
$614.65
Return
-6.1%
Regeneron Pharmaceuticals, Inc.
REGN
Sep 02, 2025
Signal & Target
BUY
$673.00
Start Price
$577.90
Best Price (1Y)
$821.11
Current Price
$614.65
Return
+6.4%
ITeos Therapeutics Inc
ITOS
May 14, 2025
Signal & Target
BUY
$12.00
Start Price
$6.92
Best Price (1Y)
$11.34
Current Price
$10.15
Return
+46.7%
Regeneron Pharmaceuticals, Inc.
REGN
Nov 01, 2024
Signal & Target
BUY
$1,195.00
Start Price
$843.60
Best Price (1Y)
$862.00
Current Price
$614.65
Return
-27.1%
Biogen Inc
BIIB
Oct 30, 2024
Signal & Target
BUY
$315.00
Start Price
$181.18
Best Price (1Y)
$185.00
Current Price
$198.64
Return
+9.6%
AMGEN Inc.
AMGN
Sep 25, 2024
Signal & Target
BUY
$344.00
Start Price
$330.92
Best Price (1Y)
$335.88
Current Price
$350.53
Return
+5.9%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Sep 16, 2024
Signal & Target
BUY
$100.00
Start Price
$87.45
Best Price (1Y)
$113.51
Current Price
$123.35
Return
+41.1%
ITeos Therapeutics Inc
ITOS
Sep 16, 2024
Signal & Target
BUY
$36.00
Start Price
$16.70
Best Price (1Y)
$14.50
Current Price
$10.15
Return
-39.2%
Signal & Target
BUY
$122.00
Start Price
$86.74
Best Price (1Y)
$90.01
Current Price
$55.65
Return
-35.8%
Signal & Target
BUY
$107.00
Start Price
$88.69
Best Price (1Y)
$93.04
Current Price
$55.65
Return
-37.3%
Regeneron Pharmaceuticals, Inc.
REGN
Aug 23, 2024
Signal & Target
BUY
$1,242.00
Start Price
$1,187.66
Best Price (1Y)
$1,211.20
Current Price
$614.65
Return
-48.2%
Abbvie Inc
ABBV
Aug 23, 2024
Signal & Target
BUY
$209.00
Start Price
$197.35
Best Price (1Y)
$218.66
Current Price
$221.59
Return
+12.3%
Tyra Biosciences Inc
TYRA
Aug 15, 2024
Signal & Target
BUY
$33.00
Start Price
$21.57
Best Price (1Y)
$29.60
Current Price
$28.55
Return
+32.4%
Biogen Inc
BIIB
Jul 26, 2024
Signal & Target
BUY
$307.00
Start Price
$211.17
Best Price (1Y)
$219.44
Current Price
$198.64
Return
-5.9%
Regeneron Pharmaceuticals, Inc.
REGN
Jul 19, 2024
Signal & Target
BUY
$1,166.00
Start Price
$1,063.60
Best Price (1Y)
$1,211.20
Current Price
$614.65
Return
-42.2%
Biogen Inc
BIIB
Jul 12, 2024
Signal & Target
BUY
$313.00
Start Price
$236.80
Best Price (1Y)
$237.98
Current Price
$198.64
Return
-16.1%
Taysha Gene Therapies Inc
TSHA
Jul 01, 2024
Signal & Target
BUY
$7.00
Start Price
$2.24
Best Price (1Y)
$3.31
Current Price
$5.97
Return
+166.5%
Abbvie Inc
ABBV
Jun 18, 2024
Signal & Target
BUY
$190.00
Start Price
$171.36
Best Price (1Y)
$218.66
Current Price
$221.59
Return
+29.3%
Alx Oncology Holdings Inc
ALXO
Jun 03, 2024
Signal & Target
BUY
$21.00
Start Price
$9.10
Best Price (1Y)
$8.78
Current Price
$1.58
Return
-82.6%
Ultragenyx Pharmaceutical Inc.
RARE
May 31, 2024
Signal & Target
BUY
$135.00
Start Price
$38.65
Best Price (1Y)
$60.37
Current Price
$25.38
Return
-34.3%
Ardelyx Inc
ARDX
May 24, 2024
Signal & Target
BUY
$15.00
Start Price
$7.20
Best Price (1Y)
$7.18
Current Price
$5.69
Return
-21.0%
Biogen Inc
BIIB
May 22, 2024
Signal & Target
BUY
$335.00
Start Price
$225.21
Best Price (1Y)
$237.98
Current Price
$198.64
Return
-11.8%
Regeneron Pharmaceuticals, Inc.
REGN
May 20, 2024
Signal & Target
BUY
$1,000.00
Start Price
$982.29
Best Price (1Y)
$1,211.20
Current Price
$614.65
Return
-37.4%
Vertex Pharmaceuticals, Inc.
VRTX
May 07, 2024
Signal & Target
BUY
$456.00
Start Price
$413.42
Best Price (1Y)
$519.88
Current Price
$450.69
Return
+9.0%
Blueprint Medicines Corp
BPMC
May 03, 2024
Signal & Target
SELL
$104.00
Start Price
$106.29
Best Price (1Y)
$73.08
Current Price
$129.46
Return
-21.8%
Deciphera Pharmaceuticals Inc
DCPH
Apr 29, 2024
Signal & Target
BUY
$25.60
Start Price
$25.25
Best Price (1Y)
$25.61
Current Price
$25.59
Return
+1.3%
Deciphera Pharmaceuticals Inc
DCPH
Apr 29, 2024
Signal & Target
SELL
$25.00
Start Price
$25.29
Best Price (1Y)
$25.56
Current Price
$25.59
Return
-1.2%
Ultragenyx Pharmaceutical Inc.
RARE
Apr 15, 2024
Signal & Target
BUY
$130.00
Start Price
$42.87
Best Price (1Y)
$60.37
Current Price
$25.38
Return
-40.8%
Taysha Gene Therapies Inc
TSHA
Apr 09, 2024
Signal & Target
BUY
$9.00
Start Price
$2.68
Best Price (1Y)
$3.31
Current Price
$5.97
Return
+122.8%
Q32 Bio Inc.
QTTB
Apr 02, 2024
Signal & Target
BUY
$45.00
Start Price
$18.00
Best Price (1Y)
$53.73
Current Price
$12.64
Return
-29.8%
Solid Biosciences Inc
SLDB
Mar 13, 2024
Signal & Target
BUY
$20.00
Start Price
$12.23
Best Price (1Y)
$10.37
Current Price
$7.36
Return
-39.8%
Abbvie Inc
ABBV
Nov 09, 2023
Signal & Target
BUY
$170.00
Start Price
$142.03
Best Price (1Y)
$207.32
Current Price
$221.59
Return
+56.0%
AMGEN Inc.
AMGN
Dec 05, 2022
Signal & Target
BUY
$297.00
Start Price
$285.73
Best Price (1Y)
-
Current Price
$350.53
Return
+22.7%
CalciMedica Inc
CALC
Nov 22, 2022
Signal & Target
SELL
$2.00
Start Price
$146.90
Best Price (1Y)
-
Current Price
$0.87
Return
+99.4%
Graybug Vision Inc
GRAY
Nov 22, 2022
Signal & Target
SELL
$2.00
Start Price
$146.90
Best Price (1Y)
$5.02
Current Price
$5.50
Return
+96.3%
Signal & Target
BUY
$128.00
Start Price
$92.10
Best Price (1Y)
-
Current Price
$55.65
Return
-39.6%
Ultragenyx Pharmaceutical Inc.
RARE
Jul 28, 2022
Signal & Target
BUY
$130.00
Start Price
$51.88
Best Price (1Y)
-
Current Price
$25.38
Return
-51.1%
Ultragenyx Pharmaceutical Inc.
RARE
May 18, 2022
Signal & Target
BUY
$135.00
Start Price
$47.70
Best Price (1Y)
-
Current Price
$25.38
Return
-46.8%
Blueprint Medicines Corp
BPMC
May 18, 2022
Signal & Target
BUY
$65.00
Start Price
$55.50
Best Price (1Y)
-
Current Price
$129.46
Return
+133.3%
Kinnate Biopharma Inc
KNTE
May 18, 2022
Signal & Target
BUY
$30.00
Start Price
$9.96
Best Price (1Y)
-
Current Price
$2.65
Return
-73.4%
CalciMedica Inc
CALC
May 18, 2022
Signal & Target
SELL
$2.00
Start Price
$171.81
Best Price (1Y)
-
Current Price
$0.87
Return
+99.5%
Graybug Vision Inc
GRAY
May 18, 2022
Signal & Target
SELL
$2.00
Start Price
$171.81
Best Price (1Y)
$5.02
Current Price
$5.50
Return
+96.8%
Biogen Inc
BIIB
Apr 07, 2022
Signal & Target
SELL
$200.00
Start Price
$211.64
Best Price (1Y)
-
Current Price
$198.64
Return
+6.1%
AMGEN Inc.
AMGN
Feb 08, 2022
Signal & Target
BUY
$255.00
Start Price
$238.96
Best Price (1Y)
-
Current Price
$350.53
Return
+46.7%
Abbvie Inc
ABBV
Feb 02, 2022
Signal & Target
BUY
$160.00
Start Price
$138.62
Best Price (1Y)
-
Current Price
$221.59
Return
+59.9%
Ultragenyx Pharmaceutical Inc.
RARE
Sep 27, 2021
Signal & Target
BUY
$170.00
Start Price
$88.66
Best Price (1Y)
-
Current Price
$25.38
Return
-71.4%